Morning Overview on MSN
Study: Breath test could track antibiotic levels and treatment response
Researchers have shown that antibiotic concentrations can be detected and measured in the exhaled breath of patients receiving intravenous treatment, raising the possibility that a simple breath test ...
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...
SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...
Abstract: The paper presents single event upset (SEU) experimental results in Spartan-6 FPGA due to direct and indirect proton ionization. High energy proton beam and aluminum foils were used to ...
The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...
Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...
InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results